IL98198A - Pharmaceutical compositions containing 4-(4-chlorophenylsulphonylcarbamoyl) benzoyl-L-valyl-L- proline-1 (RS)-(1-trifluoroacetyl-2-methylpropyl) amide - Google Patents

Pharmaceutical compositions containing 4-(4-chlorophenylsulphonylcarbamoyl) benzoyl-L-valyl-L- proline-1 (RS)-(1-trifluoroacetyl-2-methylpropyl) amide

Info

Publication number
IL98198A
IL98198A IL9819891A IL9819891A IL98198A IL 98198 A IL98198 A IL 98198A IL 9819891 A IL9819891 A IL 9819891A IL 9819891 A IL9819891 A IL 9819891A IL 98198 A IL98198 A IL 98198A
Authority
IL
Israel
Prior art keywords
pharmaceutically acceptable
treatment
valyl
proline
benzoyl
Prior art date
Application number
IL9819891A
Other languages
English (en)
Other versions
IL98198A0 (en
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of IL98198A0 publication Critical patent/IL98198A0/xx
Publication of IL98198A publication Critical patent/IL98198A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9819891A 1990-05-24 1991-05-21 Pharmaceutical compositions containing 4-(4-chlorophenylsulphonylcarbamoyl) benzoyl-L-valyl-L- proline-1 (RS)-(1-trifluoroacetyl-2-methylpropyl) amide IL98198A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/528,656 US5162348A (en) 1990-05-24 1990-05-24 Treatment of cystic fibrosis

Publications (2)

Publication Number Publication Date
IL98198A0 IL98198A0 (en) 1992-06-21
IL98198A true IL98198A (en) 1996-01-31

Family

ID=24106592

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9819891A IL98198A (en) 1990-05-24 1991-05-21 Pharmaceutical compositions containing 4-(4-chlorophenylsulphonylcarbamoyl) benzoyl-L-valyl-L- proline-1 (RS)-(1-trifluoroacetyl-2-methylpropyl) amide

Country Status (8)

Country Link
US (1) US5162348A (ja)
EP (1) EP0458535A3 (ja)
JP (1) JPH04235132A (ja)
AU (1) AU648079B2 (ja)
CA (1) CA2043132A1 (ja)
IE (1) IE911696A1 (ja)
IL (1) IL98198A (ja)
ZA (1) ZA913844B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0458537B1 (en) * 1990-05-24 1999-03-31 Zeneca Limited Use of a therapeutic compound for the treatment of bronchitis
DE69129083T2 (de) * 1990-05-24 1998-07-09 Zeneca Ltd Therapeutisches Mittel zur Vorbeugung und Behandlung des Atemnotsyndroms bei Erwachsenen
GB9014132D0 (en) * 1990-06-25 1990-08-15 Ici Plc Agent for therapy
EP0551445A4 (en) * 1990-10-05 1994-05-11 Univ North Carolina Method of administering amiloride
GB9113164D0 (en) * 1991-06-18 1991-08-07 Ici Plc Pharmaceutical agent
US5830854A (en) * 1992-12-14 1998-11-03 Merck Sharp & Dohme, Limited Method of treating cystic fibrosis using a tachykinin receptor antagonist
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5767084A (en) * 1995-10-06 1998-06-16 The Curators Of The University Of Missouri Method of treatment for cystic fibrosis and peptides for same
WO1998031706A1 (en) * 1997-01-15 1998-07-23 Johns Hopkins University METHODS OF TREATING LUNG INFECTIONS WITH HUMAN TRACHEAL ANTIMICROBIAL PEPTIDE (hTAP)
US6926911B1 (en) * 1998-12-22 2005-08-09 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000077A1 (en) * 1984-06-14 1986-01-03 Cortech, Inc. Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
DE68925923T2 (de) * 1988-06-10 1996-11-14 Merck & Co Inc Antigene der einzigen Spaltungsstelle von Fibrinogen durch Elastase
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
NO177716C (no) * 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
EP0458537B1 (en) * 1990-05-24 1999-03-31 Zeneca Limited Use of a therapeutic compound for the treatment of bronchitis
DE69129083T2 (de) * 1990-05-24 1998-07-09 Zeneca Ltd Therapeutisches Mittel zur Vorbeugung und Behandlung des Atemnotsyndroms bei Erwachsenen

Also Published As

Publication number Publication date
CA2043132A1 (en) 1991-11-25
ZA913844B (en) 1992-02-26
EP0458535A2 (en) 1991-11-27
AU7719791A (en) 1991-11-28
IE911696A1 (en) 1991-12-04
AU648079B2 (en) 1994-04-14
IL98198A0 (en) 1992-06-21
JPH04235132A (ja) 1992-08-24
US5162348A (en) 1992-11-10
EP0458535A3 (en) 1992-07-08

Similar Documents

Publication Publication Date Title
US5162348A (en) Treatment of cystic fibrosis
JP2007527398A (ja) 肺細菌感染症の治療および予防のための吸入可能なアズトレオナムリシナート製剤
US4853416A (en) Solutions of pentamidine
EP0458537B1 (en) Use of a therapeutic compound for the treatment of bronchitis
GB2224932A (en) Pharmaceutical solution containing cromogycic acid and salbutamol
EP0338670B1 (en) Pharmaceutical Compositions
ZA200503711B (en) An aqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture for use by nasal administration in treating thromboembolism
US5338727A (en) Therapeutic agent for the prevention or treatment of adult respiratory distress syndrome
MXPA01006698A (es) Solucion de las al monosodica de la n-[o-(p-pivaloiloxibencensulfonilamino)benzoil]glilicina tetrahidratada y producto farmaceutico de la misma.
US5128322A (en) Agent for therapy
CN111789827A (zh) 一种硫酸依替米星雾化吸入用制剂及其制备方法
JP3125083B2 (ja) Ｔｎｆ過剰産生抑制剤
IE63090B1 (en) Pentamidine solutions
US20090018106A1 (en) Intravenous formulations of pyridoxal 5'- phosphate and method of preparation
JPH0242027A (ja) 経粘膜吸収促進剤及びこれを用いた経鼻投与剤
JPH01233230A (ja) 経粘膜吸収促進剤及びこれを用いた点鼻剤
JPH03220131A (ja) カソキシンｃを有効成分とする血圧降下剤
SYKES ANITA RAMPLING RODERIC E. WARREN
JPH0788304B2 (ja) 高アンモニア血症治療剤
CA2603334A1 (en) Intravenous formulations of pyridoxal 5'-phosphate and method of preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed